In addition to the Pilot Programs, CWRU’s CTSC regularly solicits proposals for other funding opportunities from NIH’s National Center for Advancing Translational Sciences (NCATS) throughout the year. Some current opportunities are described below. These lists are regularly reviewed and updated.
National Center for Advancing Translational Sciences (NCATS)
RFA-TR-22-030: Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed). Next due date July 15, 2024
PA-23-189: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp—Clinical Trial Not Allowed). Due dates vary by awarding institute or center.
See a full list of NCATS funding opportunities
Special Interest
NOT-OD-24-079: Notice of Special Interest: Women’s Health Research
Addiction/Pain Management
RFA-NS-22-034: HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed). Next due date: December 07, 2024
RFA-NS-23-006: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed). Next due date: March 4, 2025
RFA-NS-24-021: HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 Clinical Trial Optional). Next due date February 6, 2025
PAR-24-197: HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) Next due date: October 16, 2024
Alzheimer’s Disease
PAR-21-112: Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32). Next due date September 25, 2023.
Cancer
PAR-22-216: NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional). Next due date October 10, 2023.
PAR-24-153. The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional). Next due date February 18, 2026
PAR-23-259. Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional). Next due date October 05, 2024
Chronic Conditions
RFA-OD-23-014: Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional). Next due date June 20, 2024 Related R21 due June 20, 2024
PAR-22-104: Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional). Next due date July 15, 2024
Communication Disorders
RFA-DC-24-001. BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required). Next due date September 19, 2025
PAR-24-166. Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education Experiences and/or Mentoring Networks (R25 - Independent Clinical Trial Not Allowed). Next due date September 29, 2025
Community-Engaged Research
RFA-DA-23-032. NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional). Next due date November 14, 2024
PAR-22-210. Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional). Next due date October 05, 2024
COVID-19
PAR-24-203. Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed). Next due date October 04, 2024
Diabetes
PAR-24-094. NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) Next due date October 09, 2024. Associated links: PAR-24-102 , U01 Research Project (Cooperative Agreements); PAR-24-103 , U01 Research Project (Cooperative Agreements)
PAR-23-119. Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed). Next due date October 16, 2024, Associated links: PAR-23-293 (R01 Clinical Trial Optional), PAR-23-294 (R21 Clinical Trial Optional) and PAR-23-295 (R03 Clinical Trial Optional)
Environmental Health
PAR-22-210: Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional). Next due date October 5, 2024
PAR-23-294. Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional). Next due date October 21, 2024
Genomics
PAR-23-132: NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed). Next due date October 16, 2024
Health Equity
National Institute on Minority Health and Health Disparities Funding Opportunities
RFA-AA-006: Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required). Due date October 18, 2024
RFA-EB-21-001: Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional). Next due date January 21, 2025
PAR-22-145: Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional). Next due date October 5, 2024
PAR-22-064: Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional). Next due date October 5, 2024
RFA-OD-22-028: The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional). Next due date November 22, 2024.
Integrative Medicine: NCCIH
RFA-DA-24-041: BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trials Not Allowed). Due date October 9, 2024
RFA-DA-24-040: BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trial Optional). Due date October 9, 2024
PAR-24-083: NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required). Associated links: PAR-24-083, R01 Research Project, PAR-24-086 , R01 Research Project
PAR-24-087, U24 Resource-Related Research Project (Cooperative Agreements)
PAR-24-090, UG3/ UH3 Phase 1 Exploratory/Developmental Cooperative Agreement/Exploratory/Developmental Cooperative Agreement Phase II, Due date October 21, 2024.
See a full list of NCCIH funding opportunities
KL2 Scholars
PAR-21-121: Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional). Next due date October 17, 2024
Maternal and Child Health
PAR-23-130: Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional). Next due date October 5, 2024
PAR-23-131: Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional). Next due date October 16, 2024.
PAR-24-059. Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional). Next due date October 05, 2024
Mental Health
PAR-22-155: Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional). Next due date June 9, 2025.
Multimorbidity
RFA-AG-004: Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Older Adults (UG3/UH3 Clinical Trial Required) Due date October 10, 2024
Research Education
PAR-23-030: Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32). Next due date January 25, 2024
Translational Science
RFA-DC-22-001: NICDC Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional). Next due date October 18, 2023.
PAR-23-200: National Eye Institute Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed). Next due date February 16, 2025
Veterans Administration
RFA-AT-24-004: NIH-DoD-VA Pain Management Collaboratory Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required). Next due date September 13, 2023.
Private Foundations or Non-Profits
Hope Foundation for Cancer Research
Lung Cancer Foundation of America (Membership Required). LCFA/BMS/ILCF Disparities in Clinical Oncology Research Grants in Translational Immuno-oncology. Due date September 5, 2023 (next due date February 28, 2024).
McKnight Research Foundation: Clinical Translational Research Scholarship in Cognitive Aging and Age-Related Memory Loss. Application window closes September 14, 2023. Notification January 2024.
National Ataxia Foundation: Pioneer SCA3 Translational Research Awards. Letter of intent due September 15, 2023. Application due November 20, 2023.
Robert Wood Johnson Foundation
Search for Funding
Pilot Program funding should lead to funding from government agencies and private foundations. Explore the links below to find the right funding opportunities to take your Pilot Project to the next stage.
| NIH | NIH is the world’s largest funder of biomedical research. Search NIH’s funding list and learn about grants and other resources. |
| National Science Foundation | Browse the NSF’s current funding opportunities. |
| Department of Defense | The Congressionally Directed Medical Research Program has a variety of funding opportunities focused on transforming healthcare through innovative and impactful research. |
| Grants.gov |
Grants.gov is a centralized location for grant seekers to find and apply for funding opportunities from all departments of the federal government. |
| Foundations | CWRU subscribes to Pivot, a service available to all faculty, staff researchers, and graduate students that helps you quickly discover the right funding opportunities. Follow the link above for the Office of Research & Grant Development’s quick start guide. |